New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
Items 801–900 of 1,000
Chang, H., Zhang, X., Li, B., & Meng, X. (2021) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.4394 · Cited by 11
“15,16 PARP1, serving as the first responder that could detect DNA strand breaks, has been unveiled to play an expansive and multifaceted role in the process of cellular response to damage on DNA, and accumulating evidence has suggested the participation of PARP1 in pathways of repairing DNA damage…”
Liu, Q., Knobloch, G., Voorneveld, J., Meeuwenoord, N. J., Overkleeft, H. S., van der Marel, G. A., Ladurner, A. G., & Filippov, D. V. (2021) · Chemical Science · doi:10.1039/d1sc02340c · Cited by 11
Stock, A. J., & Liu, Y. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.785171 · Cited by 10
Soni, A., Lin, X., Mladenov, E., Mladenova, V., Stuschke, M., & Iliakis, G. E. (2022) · Cancers · doi:10.3390/cancers14225619 · Cited by 10
Yang, X., Wang, J., Li, S., Li, X., Gong, J., Yan, Z., Zhou, H., Wu, C., & Liu, X. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad525 · Cited by 10
Jiang, S., Ren, J., Zhang, Q., Liu, W., Liu, H., Xu, Q., Tian, X., & Zhang, C. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02376 · Cited by 10
GmPARPs differentially regulate the drought and heat stress tolerance in soybean
Tiwari, R., Singh, A. K., & Rajam, M. V. (2023) · Plant Growth Regulation · doi:10.1007/s10725-023-01047-4 · Cited by 12
“(Hayashi et al. 1983; Kiehlbauch et al. 1993; D’Amours et al. 1999; Gibson and Kraus 2012; Brady et al. 2019).”
BackgroundJeong, H.-W., Ryu, T. H., Lee, H., Kim, K., & Jeong, R. (2023) · The Plant Pathology Journal · doi:10.5423/ppj.oa.08.2023.0112 · Cited by 10
“The PARPs accumulate in response to genotoxic stress for DNA repair at the damage sites (Gibson and Kraus, 2012; Song et al., 2015).”
PREVENTING THE CHROMOSOMAL TRANSLOCATIONS THAT CAUSE CANCER.
Hromas, R., Williamson, E. A., Lee, S., & Nickoloff, J. A. (2016) · PubMed · Cited by 10
Koo, J., Yoon, H., Kim, W., Cha, D., & Choi, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030779 · Cited by 10
A Novel Reciprocal Crosstalk between RNF168 and PARP1 to Regulate DNA Repair Processes.
Kim, J. J., Lee, S. Y., Kim, S., Chung, J. M., Kwon, M., Yoon, J. H., Park, S., Hwang, Y., Park, D., Lee, J.-S., et al. (2018) · PubMed Central · doi:10.14348/molcells.2018.0078 · Cited by 10
“Cells 2018; 41(8): 799-807 PARylation is an important post-translational modification, which regulates diverse intracellular signals, such as the DDR process, transcriptional regulation, RNA interference, cell division, cell survival, and death (Gibson and Kraus, 2012; Luo and Kraus).”
BackgroundTan, A., Younis, A. Z., Evans, A., Creighton, J. V., Coveny, C., Boocock, D. J., Sale, C., Lavery, G. G., Coutts, A. S., & Doig, C. L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01420-2 · Cited by 11
“ADPR units can be mono- or poly-elongated: the latter produces poly-ADPR (PAR) chains, in a process termed PARylation [1].”
BackgroundPrivileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs
Nizi, M. G., Sarnari, C., & Tabarrini, O. (2023) · Molecules · doi:10.3390/molecules28155849 · Cited by 10
“Abbreviations ADE adenine ribose ARTs ADP-ribosyltransferase ARTDs diphtheria-toxin-like ADP-ribosyltransferases BRCA breast cancer gene BRET bioluminescence resonance energy transfer CuAAC copper assisted azide alkyne cycloaddition ERα estrogen receptor HDAC histone deacetylase Hyt hydrophobic tagging HR homologous r…”
BackgroundInfluentialUchiumi, F., Larsen, S. H., & Tanuma, S. (2015) · InTech eBooks · doi:10.5772/59588 · Cited by 12
“PARP1 enzyme synthesizes poly(ADP-ribose)s on various target proteins, including p53 [18, 19] and PARP1 itself to regulate DNA-repair synthesis [20].”
BackgroundKamata, T., Yang, C., Jividen, K., Spencer, A., Dworak, N. M., Oostdyk, L. T., & Paschal, B. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9195-2_9 · Cited by 10
PARP Inhibition Synergizes with Melphalan but Does not Reverse Resistance Completely
Patel, P. R., Senyuk, V. I., Sweiss, K. I., Calip, G. S., Pan, D., Rodriguez, N. S., Oh, A. L., Mahmud, N., & Rondelli, D. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.03.008 · Cited by 12
Qian, P., Mu, X.-T., Su, B., Gao, L., & Zhang, D. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03143-8 · Cited by 14
“PARP1 is a base excision repair protein that could promote cancer cell survival, and is an effective target in triple-negative breast cancer [58, 59].”
BackgroundPoly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics
Li, N., Wang, Y., Deng, W., & Lin, S. H. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666181109164645 · Cited by 11
Li, H., Chatla, S., Liu, X., Tian, Z., Vekariya, U. M., Wang, P., Kim, D. W., Octaviani, S., Lian, Z., Morton, G. C., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217505 · Cited by 9
Recent Progress in the Research on Benzimidazole PARP-1 Inhibitors
Cao, X., Wu, K., Chen, M., Peng, X., Li, Y., Tang, G., & Peng, J. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220321150700 · Cited by 9
Wan, S., Chen, X., Yin, F., Li, S., Zhang, Y., Luo, H., Luo, Z., Cui, N., Chen, Y., Li, X., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115843 · Cited by 9
High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair
Dhakar, S. S., Galera‐Prat, A., & Lehtiö, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-54123-8 · Cited by 10
“In order to generate a signal that can be used in high-throughput mode to discover protein–protein interaction inhibitors as potential starting points for drug development, we decided to label the proteins with fluoro-phores to develop a FRET assay.”
BackgroundTargeting selective inhibitors of PARPs in drug discovery and development
Duan, M., Gao, J., Li, J., Huang, X., Ren, Y., Li, Y., Liao, M., & Zhang, Y. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03282-4 · Cited by 10
“Poly(ADP-ribose)polymerases (PARPs), as the nuclear enzymes, are acknowledged for their capacity to facilitate the PARylation process, involving the transfer of ADP-ribose residues from nicotinamide adenine dinucleotide (NAD + ) onto designated substrates [1 – 3].”
InfluentialCation-induced intramolecular coil-to-globule transition in poly(ADP-ribose)
Wang, T., Coshic, K., Badiee, M., McDonald, M. R., Aksimentiev, A., Pollack, L., & Leung, A. K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-51972-9 · Cited by 11
The Role of Poly(ADP-Ribose) Polymerase-1 in Cutaneous Wound Healing
Banerjee, J., Lodhi, N., & Nguyen, B.-N. H. (2019) · Advances in Wound Care · doi:10.1089/wound.2018.0821 · Cited by 9
“in facilitating wound healing PARP inhibitors have been well studied for their therapeutic efficacy in a variety of diseases,(103,104) although most of the clinical trials have been aimed at cancers.(105) Topically applied pharmacological inhibitors have been shown to accelerate wound closure in mouse models of excisi…”
BackgroundLi, F., Wu, X., Fu, X., Liu, J., Song, W., Xiao, G. G., Lü, A., & Zhang, G. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.58784 · Cited by 9
“PARP inhibitors bind to the NAD binding pocket in the catalytic domain of PARPs and hinder the synthesis of PAR [11-13].”
BackgroundInteractions and interplay of MLOs with classical membrane-bound organelles
Sasidharan, S., Nag, N., Tripathi, T., & Saudagar, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823967-4.00024-5 · Cited by 10
Impact of Asp/Glu‐ADP‐ribosylation on protein‐protein interaction and protein function
Pei, J., Zhang, J., Wang, X., Kim, C., Yu, Y., & Cong, Q. (2022) · PROTEOMICS · doi:10.1002/pmic.202200083 · Cited by 9
KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway.
Wan, Y., Morikawa, M., Morikawa, M., Iwata, S., Naseer, M. I., Chaudhary, A., Tanaka, Y., & Hirokawa, N. (2023) · PubMed Central · doi:10.1083/jcb.202208108 · Cited by 13
“The transcriptional role of PARP1 is mainly controlled by its physiological activation-produced poly (ADP-ribose; PAR), a posttranscriptional modifier composed of a polymer of two or more ADP-ribose units (Gibson and Kraus, 2012).”
Calabrese, M., Saporita, I., Turco, F., Gillessen, S., Castro, E., Vogl, U. M., Stefano, R. F. D., Carfì, F. M., Poletto, S., Farinea, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010078 · Cited by 9
“This explains why cancer cells de fi cient in BRCA1 and BRCA2 are hypersensitive to PARPi. protein, which results in the unwinding of the DNA strands and recruitment of proteins on the damaged DNA through the base-excision repair process [56].”
BackgroundThe Impact of Genomics on Oncology Nursing
Beamer, L. C., Linder, L. A., Wu, B., & Eggert, J. A. (2013) · Nursing Clinics of North America · doi:10.1016/j.cnur.2013.09.007 · Cited by 9
Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.
Weilandt, M., Koch, A., Rieder, H., Deenen, R., Schwender, H. R., Niegisch, G., & Schulz, W. A. (2014) · PubMed · Cited by 9
Detecting Protein ADP-Ribosylation Using a Clickable Aminooxy Probe
Morgan, R. K., & Cohen, M. S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6993-7_6 · Cited by 9
“The PARP family consists of 17 enzymes in humans that catalyze the transfer of ADP-ribose (ADPr) from nicotinamide adenine dinucleotide (NAD+) to amino acids on target proteins [1].”
BackgroundMayo, E., Fabrizio, G., Scarpa, E. S., Stilla, A., Dani, N., Chiacchiera, F., Kleine, H., Attanasio, F., Lüscher, B., & Girolamo, M. D. (2018) · Challenges · doi:10.3390/challe9010022 · Cited by 9
Moesslacher, C. S., Kohlmayr, J. M., & Stelzl, U. (2021) · Microbial Cell · doi:10.15698/mic2021.08.756 · Cited by 11
“Poly(ADP-ribose) polymerases (PARPs) transfer ADPribose from NAD+ to target proteins forming long linear or, less frequently, branched chains [70, 71].”
Dictyostelium discoideum as a Model to Assess Genome Stability Through DNA Repair
Pears, C. J., Brustel, J., & Lakin, N. D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.752175 · Cited by 9
Ağca, C. A., Tykhomyrov, A. A., Baydaş, G., & Nedzvetsky, V. S. (2017) · Neurophysiology · doi:10.1007/s11062-017-9680-4 · Cited by 11
“transcription, DNA damage repair, and mRNA stability [19].”
Noro, E., Yokoyama, A., Kobayashi, M., Shimada, H., Suzuki, S., Hosokawa, M., Takehara, T., Parvin, R., Shima, H., Igarashi, K., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051406 · Cited by 11
“PARP1 belongs to a group of ADP-ribosyl transferase enzymes, which transfer ADP-ribose groups of donor NAD+ molecules onto their target proteins, and PARP family proteins control a wide array of cellular processes including DNA repair and transcription [27].”
BackgroundInfluentialA novel conserved family of Macro-like domains—putative new players in ADP-ribosylation signaling
Dudkiewicz, M., & Pawłowski, K. (2019) · PeerJ · doi:10.7717/peerj.6863 · Cited by 10
Wen, M., Qiu, Y., Wang, M., Tang, F., Hu, W., Zhu, Y., Zhao, W., Hu, W., Chen, Z., Duan, Y., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03207-w · Cited by 10
“PARP1 functions as an early DNA damage sensor, orchestrating a wide array of downstream DNA repair factors through PARylation [22, 23, 29].”
PARP-1 as a novel target in endocrine-resistant breast cancer
Zicarelli, A., Talia, M., Lainé, M., Lappano, R., Maggiolini, M., & Greene, G. L. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03441-4 · Cited by 8
“PARP-1 is involved in the ADP-ribosyl transferase of many known substrates [21, 22] as well as in triggering the DNA damage response by transferring poly-ADP-ribose molecules to target proteins [23, 24].”
Babukov, Y., Aleksandrov, R., Ivanova, A., Atemin, A., & Stoynov, S. (2021) · Biomedicines · doi:10.3390/biomedicines9091238 · Cited by 8
“PARP1 binding to DNA lesions stimulates its enzymatic activity, and thereafter, PARP1 starts to synthesize and attach branched and strongly negative poly(ADP-ribose) (PAR) chains to nearby chromatin [25].”
BackgroundChae, K., Overcash, J. M., Dawson, C., Valentin, C., Tsujimoto, H., Myles, K. M., & Adelman, Z. N. (2023) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2023.100133 · Cited by 9
Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma
Jani, Y. C., Jansen, C. S., Gerke, M. B., & Bilen, M. A. (2024) · Immunotherapy · doi:10.2217/imt-2023-0267 · Cited by 8
Gao, S., Hou, Y., Xu, Y., Li, J., Zhang, C., Jiang, S., Yu, S., Liu, L., Li, L., Tu, W., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02276 · Cited by 10
Bolik-Coulon, N., Rößler, P., & Kay, L. E. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01567 · Cited by 9
Poly(ADP-ribose) protects vascular smooth muscle cells from oxidative DNA damage
Zhang, C., Luo, T., Cui, S., Gu, Y., Bian, C., Chen, Y., Yu, X., & Wang, Z. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.6.012 · Cited by 8
AXIN Shapes Tankyrase ARChitecture
Guettler, S. (2016) · Structure · doi:10.1016/j.str.2016.09.003 · Cited by 8
The effect of trans-resveratrol on the expression of the human DNA-repair associated genes
Uchiumi, F., Arakawa, J., Takihara, Y., Akui, M., Ishibashi, S., & Tanuma, S. (2016) · Integrative Molecular Medicine · doi:10.15761/imm.1000246 · Cited by 10
“The accumulated NAD+ molecule will be consumed by poly(ADP-ribose) polymerase (PARP) to induce the poly(ADP-ribosyl)ation of nuclear proteins, which is essential for DNA-repair synthesis and the regulation of the telomere length [57,58].”
BackgroundJi, M., Wang, L., Xue, N., Lai, F., Zhang, S., Jin, J., & Chen, X. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218767843 · Cited by 8
Squillaci, G., Vitiello, F., Mosca, L., Cara, F. L., Cacciapuoti, G., Porcelli, M., & Morana, A. (2022) · Molecules · doi:10.3390/molecules27082576 · Cited by 8
“To explore the mechanism of apoptosis-mediated cell death, we next analyzed the levels of cleaved caspases and PARP-1, a known target for apoptosis-associated caspase cleavage [46].”
BackgroundPoly(ADP-ribosyl)ating enzymes cooperate to coordinate development
Bordet, G., Karpova, I., & Tulin, A. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-26530-2 · Cited by 8
“The role of the PARP family, initially thought to be limited to DNA repair 3 , was progressively found to be important in many other biological processes, including chromatin compaction and loosening, as well as regulation of gene expression 5–13 .”
PARP molecular functions and applications of PARP inhibitors in cancer treatment
Guo, Y., Fan, B., & Li, M. (2023) · Genome Instability & Disease · doi:10.1007/s42764-023-00100-w · Cited by 11
“Specifically, (ADP-ribosyl) ation transferases, also known as PARPs, catalyze the covalent attachment of ADP-ribose to target proteins (Gibson & Kraus, 2012) (Fig.”
BackgroundPARP12 regulates mouse oocyte meiotic maturation
Cao, G., Guo, R., Chen, M., Sun, C., & Wang, J. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31037 · Cited by 8
“ADP‐ribosylation (ADPRylation) is a posttranslational modification of proteins using β‐NAD+ as a donor of ADPR units, which are covalently linked to a variety of amino acid residues (e.g., Glu, Asp, and Ser) of substrate proteins (Gibson & Kraus, 2012; Leung, 2017; Kim et al., 2020).”
BackgroundA ribose-functionalized NAD + with versatile activity for ADP-ribosylation
Stephens, E. N., Zhang, X., Lam, A. T., Li, J., Pei, H., Louie, S. G., Wang, C. C. C., & Zhang, Y. (2023) · Chemical Communications · doi:10.1039/d3cc04343f · Cited by 9
Radhakrishnan, S. K., Bebb, D. G., & Lees‐Miller, S. P. (2013) · Translational Cancer Research · doi:10.21037/1123 · Cited by 9
“It consists of an amino terminal DNAbinding domain which contains three zinc fingers, a central automodification domain that undergoes poly (ADPribosyl) ation, and a C-terminal catalytic domain which utilizes NAD to generate poly (ADP-ribose) polymers on itself and its target proteins (1,2).”
BackgroundChung, W.-C., Kim, J., Kim, B. C., Kang, H.-R., Son, J., Ki, H., Hwang, K. Y., & Song, M. J. (2018) · IUCrJ · doi:10.1107/s2052252518013854 · Cited by 8
“PARP-1 activity is involved in several important cellular functions such as differentiation, proliferation, malignant transformation and DNA damage repair (Kim et al., 2005; Ko & Ren, 2012; Luo & Kraus, 2012; Gibson & Kraus, 2012).”
BackgroundKobayashi, M., Ishizaki, Y., Owaki, M., Matsumoto, Y., Kakiyama, Y., Hoshino, S., Tagawa, R., Sudo, Y., Okita, N., Akimoto, K., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27581 · Cited by 8
PARP Inhibitors as Therapeutic Options for Tyrosine Kinase-dependent Leukemia: A Review
Machado, C. B., da Silva, E. L., de Moraes, M. O., de Moraes, M. E. A., & Moreira-Nunes, C. A. (2020) · Anticancer Research · doi:10.21873/anticanres.14286 · Cited by 8
Wettasinghe, A. P., Singh, N., Starcher, C. L., DiTusa, C. C., Ishak-Boushaki, Z., Kahanda, D., McMullen, R., Motea, E. A., & Slinker, J. D. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00365 · Cited by 8
Computational Approaches for Cancer-Fighting: From Gene Expression to Functional Foods
Monticolo, F., & Chiusano, M. L. (2021) · Cancers · doi:10.3390/cancers13164207 · Cited by 8
“PARP1 is involved in many different aspects of human cell biology [109].”
BackgroundSafrygin, A. V., Zhmurov, P. A., Dar’in, D. V., Silonov, S., Kasatkina, M., Zonis, Y. A., Gureev, M., & Krasavin, M. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1969386 · Cited by 8
TdT-dUTP DSB End Labeling (TUDEL), for Specific, Direct In Situ Labeling of DNA Double Strand Breaks
Lutze, J., Warrington, S. E., & Kron, S. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1811-0_18 · Cited by 9
Synthesis of disaccharide nucleoside analogues as potential poly(ADP-ribose) polymerase-1 inhibitors
Zheng, M., Mex, M., Götz, K., & Marx, A. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob01894d · Cited by 8
Qiu, F., Wang, J., Huang, K., Shang, T., Wang, C., Yan, W., Xu, Y., & Gu, H. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01335 · Cited by 7
Nanotherapeutic Strategies for Osteoarthritis: Targeting Aging, Metabolism and Inflammation
He, Z., Chen, Y., Zhao, K., Jiao, Y., Ji, Y., Mao, D., Wan, R., Zhang, J., & Hu, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s584027 · Cited by 8
“124,125 Persistent DNA damage in aging chondrocytes triggers PARP1 hyperactivation, leading to NAD + depletion and subsequent mitochondrial dysfunction, thereby exacerbating cellular senescence and SASP propagation.”
Yan, F., Fu, Z., Li, G., & Wang, Z. (2023) · Molecules · doi:10.3390/molecules28041829 · Cited by 7
“Poly(ADP-ribose) polymerases (PARPs) catalyze the transfer of single or multiple ADPribose units from nicotinamide adenine dinucleotide (NAD+) to target proteins [1], resulting in the modulation of their enzyme activity and cellular localization and the formation of multimeric protein complexes [2,3]; these processes…”
BackgroundPrudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies
Rana, M., Thakur, A., Kaur, C., Pan, C., Lee, S., Liou, J., & Nepali, K. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2241818 · Cited by 7
PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis
Qin, Y., Dong, X., Lu, M., Jing, L., Chen, Q., Guan, F., Xiang, Z., Huang, J., Yang, C., He, X., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216952 · Cited by 10
Chiu, S.-P., Camacho, C. V., & Kraus, W. L. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107609 · Cited by 7
“Some of the most well-characterized ADPR binding domains (ARBDs) include WWE domains, which recognize PAR (and oligo chains), and macrodomains, which recognize MAR or terminal ADPR moieties found in PAR (and oligo chains) (1, 3, 4, 6).”
Self-citationSingh, D. H., Deeksha, W., & Rajakumara, E. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107330 · Cited by 8
Wu, P., Chen, J., Li, H., Lu, H., Li, Y., & Zhang, J. (2024) · Oncology Reports · doi:10.3892/or.2024.8851 · Cited by 9
Das, A., Mandal, S. K., Arya, S., Samanta, S. K., Kumar, A., Panchpuri, M., Abdel‐Gawad, H., Dwibedi, V., Das, N., Bose, S., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108558 · Cited by 8
Rizvi, A., & Naseem, I. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110278 · Cited by 8
Tian, Y., Korn, P., Tripathi, P., Komnig, D., Wiemuth, D., Nikouee, A., Claßen, A., Bolm, C., Falkenburger, B. H., Lüscher, B., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-00878-1 · Cited by 7
HTS discovery of PARP1-HPF1 complex inhibitors in cancer
Kellett, T., Noor, R., Zhou, Q., Esquer, H., Sala, R., Stojanovic, P., Rudolph, J., Luger, K., & LaBarbera, D. V. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.10.003 · Cited by 8
Bordet, G., Bamgbose, G., & Tulin, A. V. (2023) · Scientific Reports · doi:10.1038/s41598-023-47691-8 · Cited by 7
A desthiobiotin labelled NAD+ analogue to uncover Poly(ADP‐ribose) polymerase 1 protein targets
Rieth, S., Spliesgar, D., Orth, J., Lehner, M., Kasprzyk, R., Stengel, F., & Marx, A. (2024) · ChemBioChem · doi:10.1002/cbic.202300797 · Cited by 7
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment
Espín, R., Medina‐Jover, F., Sigüenza-Andrade, J., Farran-Matas, S., Mateo, F., Figueras, A., Sanz, R. T., Vicent, G. P., Shabbir, A., Ruiz-Auladell, L., et al. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf007 · Cited by 7
“To assess the impact of hypoxia on alt-EJ pathway activity, we used human osteosarcoma U2OS cells with a GFP-based reporter for alt-EJ repair [ 72 ] and measured PARylation in cell extracts [ 98 ].”
The DNA Damage Response Mediates Apoptosis and Tumor Suppression
Baran, K., Rodríguez, D. A., & Green, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_7 · Cited by 8
Pitcher, D. S., de Mattos-Shipley, K. M. J., Wang, Z., Tzortzis, K. N., Goudevenou, K., Flynn, H. R., Bohn, G., Rahemtulla, A., Roberts, I. A. G., Snijders, A. P., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.08.013 · Cited by 8
Serendipitous Discovery of a Prodrug of a PARP ‐1 Inhibitor
Dunn, D. D., Husten, J., Aimone, L. D., Ator, M. A., & Chatterjee, S. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12165 · Cited by 7
Macrophage Activation: On PAR with LPS
Bock, F. J., & Chang, P. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.04.006 · Cited by 7
Effect of mild temperature shift on poly(ADP-ribose) and γH2AX levels in cultured cells
Yamashita, S., Tanaka, M., Sato, T., Ida, C., Ohta, N., Hamada, T., Uetsuki, T., Nishi, Y., Moss, J., & Miwa, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.001 · Cited by 7
Poly(ADP-Ribose) Polymerase-3 Regulates Regeneration in Planarians
Barghouth, P. G., Karabinis, P., Venegas, A., & Oviedo, N. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030875 · Cited by 8
“PARylation is an integral response that appears rapidly at sites of damaged DNA and establishes its effect through post‐translational protein modifications [4,6,7].”
BackgroundDallavalle, S., Princiotto, S., Mattio, L. M., Artali, R., Musso, L., Aviñó, A. M., Eritja, R., Pisano, C., Gargallo, R., & Mazzini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168737 · Cited by 7
“The intervention of PARP1 takes place early in the steps of the DNA repair process, after activation by DNA nicks [3].”
BackgroundBerger, N. D., Brownlee, P. M., Chen, M. J., Morrison, H., Osz, K., Ploquin, N. P., Chan, J. A.-W., & Goodarzi, A. A. (2022) · NAR Cancer · doi:10.1093/narcan/zcac012 · Cited by 7
Small Molecule Microarray Based Discovery of PARP14 Inhibitors
Peng, B., Thorsell, A. G., Karlberg, T., Schuler, H., & Yao, S. Q. (2016) · Angewandte Chemie · doi:10.1002/ange.201609655 · Cited by 7
Zhao, Q., Du, Q., Wei, F., Xie, J., & Ma, X. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601894 · Cited by 7
“PARP-1 contains three major functional units, including the DNA-binding domain comprised of two zinc finger motifs, the automodification domain that functions as the target of covalent automodification, and the catalytic domain (17).”
BackgroundFazi, F., & Fatica, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094755 · Cited by 7
“In breast cancer, H/ACA snoRNAs are also able to regulate the activity of DDX21 by interacting with the PARP enzyme [59], which catalyzes the addition of poly(ADP-ribose) (PAR) polymers on target proteins [60].”
BackgroundRecent advances in the synthesis of poly (ADP-ribose)
Wu, Y., Li, T., & Liu, Q. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118202 · Cited by 6
Discovery of highly potent PARP7 inhibitors for cancer immunotherapy
Yang, J., Liu, B., Yan, W., Zhao, X., Wang, C., Zhu, Q., Zou, Y., Xu, Y., & Gu, H. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107469 · Cited by 6
PARP inhibitors in non-ovarian gynecologic cancers
Fernandes, Í., Chehade, R., & MacKay, H. J. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241255174 · Cited by 6
Poly‐ ADP ‐ribosylation dynamics, signaling, and analysis
Al‐Rahahleh, R. Q., & Sobol, R. W. (2024) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22623 · Cited by 6
Wang, S.-Y., Xia, Y., Qian, Y., Pan, W., Huang, P., Jin, N., Li, X., Xu, C., Liu, D., Zhao, G.-N., et al. (2025) · Drug resistance updates · doi:10.1016/j.drup.2025.101247 · Cited by 7
Bisceglie, L., Bartolomei, G., & Hottiger, M. O. (2017) · Nature Protocols · doi:10.1038/nprot.2017.072 · Cited by 6
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Chen, M., Wang, W., Hu, S., Tong, Y., Li, Y., Wei, Q., Yu, L., Zhu, L., Zhu, Y., Liu, L., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00850-2 · Cited by 6
“The PARP family enzymes covalently add Poly(ADPribose) (PAR) chains on to target proteins, termed PARylation, which is involved in chromatin modification, DNA damage repair, maintenance of telomeres and so on [43].”
BackgroundKurgina, T. A., & Lavrik, O. I. (2023) · Molecular Biology · doi:10.1134/s0026893323020140 · Cited by 6
Yu, L., Li, J., Zhu, J., Wang, Y., Yan, Z., Zhang, L., & Li, S. (2023) · BMC Chemistry · doi:10.1186/s13065-023-01060-8 · Cited by 6
“Among this family, PARP-1 is the most abundant and specific isoform, exerting more than 90% of the PARP enzyme activity [3, 4].”
BackgroundGuo, T., Yuan, Y., Zou, Y., Guo, Z., Yang, T., Tang, M., Ma, Z., Fu, Z., Bo, W., Wang, P., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02463 · Cited by 8
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.